Exact Sciences Corporation
EXAS
|
$60.97
-3.95%
-4.12%
2.2M
|
Health Technology
(0.0% 1d) (-1.7% 1m) (-9.6% 1y) (0.0% 2d) (0.0% 3d) (-6.7% 7d) (-37.54% volume)
Earnings Calendar: 2024-02-21
Market Cap: $ 11,067,943,058
http://www.exactsciences.com
Sec Filling | Patents | 4110 employees
(US) EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.
cancer molecular diagnostics colorectal cancer diagnostics
add to watch list Paper trade email alert is off
Press-releases
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
Published: 2024-04-15 (Crawled : 11:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -2.91%
H: 1.81%
C: -7.4%
sciences financial
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
Published: 2024-04-08 (Crawled : 00:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
test sciences meeting study
Notice convening the Annual General Meeting in BioPorto A/S
Published: 2024-04-04 (Crawled : 09:00) - globenewswire.com
TTOO A | $2.98 -0.33% -0.34% 34K
|
Health Technology
|
| O: -5.02%
H: 5.63%
C: 0.7%
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.01%
H: 0.24%
C: -4.41%
meeting
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
Published: 2024-04-04 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.01%
H: 0.24%
C: -4.41%
cancer treatment tumor sciences
DNA Methylation Detection Technology Markets, 2033 - Intensified Competition, Increasing Adoption, PCR Dominates
Published: 2024-03-30 (Crawled : 04:20) - prnewswire.com
ABCM | $23.99 0.0% 7.4M
|
Health Technology
| Email alert
Add to watchlist
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
| Email alert
Add to watchlist
HOLX | $75.37 0.36% 0.36% 1.3M
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
PACB | $1.55 6.16% 5.81% 17M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
| Email alert
Add to watchlist
PKI | $115.24 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
ABCZF | $22.1 -2.32% 4K
|
Health Technology
| Email alert
Add to watchlist
dna technology
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
Published: 2024-03-28 (Crawled : 12:30) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
oncoguard test cancer sciences
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.43%
H: 1.9%
C: 1.06%
cologuard test results study
Global Cancer/Tumor Profiling Market Research Report 2023-2030: Multi-Omics Tumor Profiling Advances Fuel Developments, Rising Personalized Medicine Trends Driving Growth
Published: 2024-03-01 (Crawled : 23:00) - prnewswire.com
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
report tumor research global trends growth market
Exact Sciences to Participate in March 2024 Investor Conference
Published: 2024-02-26 (Crawled : 12:00) - biospace.com/
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
|
| O: -0.87%
H: 2.56%
C: 0.84%
conference sciences
Liquid Biopsy Market Set to Reach US$ 10.08 Billion by 2030 with Pioneering Breakthroughs in Cancer Detection and Management
Published: 2024-02-16 (Crawled : 19:00) - prnewswire.com
EXAS | $60.97 -3.95% -4.12% 2.2M
|
Health Technology
| Email alert
Add to watchlist
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
LH M | $201.48 1.02% 0.0% 770K
|
Health Services
| Email alert
Add to watchlist
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
| Email alert
Add to watchlist
management reach cancer set market
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10